Hormone refractory prostate cancer
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
683
|
29
|
0.020 |
None |
0.500 |
2 |
|
2003 |
2003 |
Malignant neoplasm of prostate
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4502
|
1082
|
0.080 |
None |
0.875 |
8 |
|
1999 |
2016 |
Prostate carcinoma
|
disease |
Neoplasms; Male Urogenital Diseases
|
Neoplastic Process
|
4388
|
1168
|
0.090 |
None |
0.889 |
9 |
|
1999 |
2016 |
Tumor Cell Invasion
|
phenotype |
|
Neoplastic Process
|
6626
|
169
|
0.060 |
None |
1.000 |
6 |
|
2017 |
2020 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.050 |
None |
1.000 |
5 |
|
1994 |
2019 |
Liver carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5725
|
942
|
0.040 |
None |
1.000 |
4 |
|
2015 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.030 |
None |
1.000 |
3 |
|
2001 |
2019 |
Neoplasm Metastasis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6385
|
327
|
0.030 |
None |
1.000 |
3 |
|
2017 |
2019 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.030 |
None |
1.000 |
3 |
|
2001 |
2019 |
Progression of prostate cancer
|
disease |
|
Neoplastic Process
|
398
|
7
|
0.020 |
None |
1.000 |
2 |
|
1999 |
2012 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.020 |
None |
1.000 |
2 |
|
1994 |
2018 |
Cicatrix, Hypertrophic
|
disease |
Pathological Conditions, Signs and Symptoms
|
Acquired Abnormality
|
185
|
3
|
0.020 |
None |
1.000 |
2 |
|
2008 |
2008 |
Secondary malignant neoplasm of lymph node
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
2825
|
188
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Epithelial ovarian cancer
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
1224
|
129
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Pancreatic carcinoma
|
disease |
Digestive System Diseases; Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
2689
|
322
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Malignant neoplasm of colon and/or rectum
|
disease |
|
Neoplastic Process
|
3669
|
502
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Childhood Osteosarcoma
|
disease |
Neoplasms
|
Neoplastic Process
|
2208
|
151
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Carcinoma, Ovarian Epithelial
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications; Endocrine System Diseases
|
Neoplastic Process
|
2841
|
327
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Adrenal Gland Pheochromocytoma
|
disease |
Neoplasms; Endocrine System Diseases
|
Neoplastic Process
|
416
|
50
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Obstructive azoospermia
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
74
|
9
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Nonnuclear polymorphic congenital cataract
|
disease |
|
Congenital Abnormality
|
71
|
|
0.010 |
None |
1.000 |
1 |
|
2020 |
2020 |
Intestinal fibrosis
|
phenotype |
|
Anatomical Abnormality
|
65
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Progesterone Resistance
|
disease |
Female Urogenital Diseases and Pregnancy Complications
|
Disease or Syndrome
|
29
|
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Azoospermia, Nonobstructive
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
91
|
22
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Mammary Neoplasms
|
group |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
2780
|
385
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |